Department of Pharmacy, Xuanwu Hospital of Capital Medical University, Beijing, 100053, China.
Department of Pharmacy, Xuanwu Hospital of Capital Medical University, Beijing, 100053, China.
J Ethnopharmacol. 2020 May 23;254:112586. doi: 10.1016/j.jep.2020.112586. Epub 2020 Feb 25.
With the extensive recent use of warfarin and traditional Chinese medicine (TCM) in combination, TCM has been found to affect warfarin's pharmacokinetic and pharmacodynamic parameters. Warfarin is a widely used oral anticoagulant, which has a narrow therapeutic window and a high likelihood of interacting with other drugs and resulting in serious adverse reactions. Contrary to widespread public expectations, TCM, despite being natural, is not always safe.
To report the adverse drug reactions (ADR) resulting from the use of Chinese medicine and warfarin sodium tablets in combination.
According to a hospital ADR monitoring report, we collected data on four clinical cases involving warfarin and single Chinese herbal medicine, warfarin and proprietary traditional Chinese medicine product, warfarin and Chinese medicinal injection, and warfarin and compound decoction. The Naranjo ADR score evaluation scale was used to analyze the relationships between warfarin and Chinese medicines.
Fluctuations in the international normalized ratio (INR) were accompanied by bleeding in some patients who regularly and simultaneously utilized warfarin and Chinese medicine. The potential risk of bleeding due to the interaction between TCM and warfarin is easily and often overlooked by both Western and TCM doctors.
Warfarin in combination with different traditional Chinese herbal medicines poses risks of INR fluctuations and adverse reactions such as bleeding. In the future, the safety awareness regarding reasonable administration of warfarin and herbal medicine should be emphasized.
由于最近华法林和中药(TCM)联合广泛应用,发现 TCM 会影响华法林的药代动力学和药效动力学参数。华法林是一种广泛使用的口服抗凝剂,其治疗窗较窄,与其他药物相互作用的可能性较高,导致严重不良反应的可能性较大。与普遍的公众期望相反,TCM 尽管是天然的,但并不总是安全的。
报告华法林钠片与中药联合使用引起的不良反应(ADR)。
根据医院 ADR 监测报告,我们收集了涉及华法林和单味中药、华法林和中药专利产品、华法林和中药注射液以及华法林和复方汤剂的 4 例临床病例数据。采用 Naranjo ADR 评分评估量表分析华法林与中药之间的关系。
一些患者在定期同时使用华法林和中药时,国际标准化比值(INR)波动伴有出血。TCM 和华法林之间的相互作用导致出血的潜在风险很容易被西医和中医医生忽视。
华法林与不同的中药联合使用存在 INR 波动和出血等不良反应的风险。今后,应强调合理应用华法林和草药的安全意识。